New phenothiazine-type multidrug resistance modifiers:: anti-MDR activity versus membrane perturbing potency

被引:36
作者
Hendrich, AB
Wesolowska, O
Motohashi, N
Molnár, J
Michalak, K
机构
[1] Wroclaw Med Univ, Dept Biophys, PL-50368 Wroclaw, Poland
[2] Meiji Pharmaceut Univ, Dept Med Chem, Kiyose, Tokyo 2048588, Japan
[3] Albert Szent Gyorgvi Med Univ, Inst Microbiol, H-6720 Szeged, Hungary
关键词
phenothiazine derivatives; multidrug resistance reversal; drug-lipid interactions; lipid bilayer fluidity; P-glycoprotein;
D O I
10.1016/S0006-291X(03)00580-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The phenothiazine multidrug resistance (MDR) modulators are chemically diversified but share the common feature to be hydrophobic cationic molecules. Molecular mechanisms of their action may involve interactions with either P-glycoprotein or Membrane lipid matrix. In the present work we study the anti-MDR and biophysical membrane effects of new phenothiazine derivatives differing in the type of group substituting phenothiazine ring at position 2 (H-, CI-, CF3-) and in the side chain group (NHCO2CH3 or NHSO2CH3). Within each phenothiazine subset we found that anti-MDR activity (determined by P-glycoprotein inhibition assessed by flow cytometry) correlates with the theoretically calculated hydrophobicity value (log P) and experimental parameters (determined by calorimetry and fluorescence spectroscopy) of lipid bilayers. It is concluded that the biological and biophysical activity of phenothiazine derivatives depends more on the type of ring substitution than on the nature of the side chain group. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:260 / 265
页数:6
相关论文
共 40 条
[31]   A RETROVIRUS CARRYING AN MDR1 CDNA CONFERS MULTIDRUG RESISTANCE AND POLARIZED EXPRESSION OF P-GLYCOPROTEIN IN MDCK CELLS [J].
PASTAN, I ;
GOTTESMAN, MM ;
UEDA, K ;
LOVELACE, E ;
RUTHERFORD, AV ;
WILLINGHAM, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4486-4490
[32]   REVERSAL OF MULTIDRUG RESISTANCE BY PHENOTHIAZINES AND STRUCTURALLY RELATED-COMPOUNDS [J].
RAMU, A ;
RAMU, N .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (03) :165-173
[33]   INFLUENCE OF CHLORPROMAZINE ON THE TRANSVERSE MOBILITY OF PHOSPHOLIPIDS IN THE HUMAN-ERYTHROCYTE MEMBRANE - RELATION TO SHAPE CHANGES [J].
ROSSO, J ;
ZACHOWSKI, A ;
DEVAUX, PF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 942 (02) :271-279
[34]   A general pattern for substrate recognition by P-glycoprotein [J].
Seelig, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 251 (1-2) :252-261
[35]   Structure-activity relationship of P-glycoprotein substrates and modifiers [J].
Seelig, A ;
Landwojtowicz, E .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (01) :31-40
[36]  
TSURUO T, 1982, CANCER RES, V42, P4730
[37]   THE ROLE OF DRUG LIPID INTERACTIONS IN THE BIOLOGICAL-ACTIVITY OF MODULATORS OF MULTIDRUG-RESISTANCE [J].
WADKINS, RM ;
HOUGHTON, PJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1153 (02) :225-236
[38]   THE EFFECT OF ION-CHANNEL BLOCKERS, IMMUNOSUPPRESSIVE AGENTS, AND OTHER DRUGS ON THE ACTIVITY OF THE MULTIDRUG TRANSPORTER [J].
WEAVER, JL ;
SZABO, G ;
PINE, PS ;
GOTTESMAN, MM ;
GOLDENBERG, S ;
ASZALOS, A .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (03) :456-461
[39]  
WESOLOWSKA O, 2001, CURR TOPICS BIOPHYS, V25, P71
[40]  
ZAMORA JM, 1988, MOL PHARMACOL, V33, P454